- Advertisement -

Global Deoxyguanosine Market 2019 Nantong Qiuzhiyou Bioscience&biotechnology, Tuoxin Group, Ribio, Hongene Biotechnology – Market News Report

The “Global Deoxyguanosine Market 2018 Research Report” is an extensive Deoxyguanosine Market research report contains an introduction on new trends that can guide the...

IR-Based Cell Imaging System Filters Out Water’s Effects, Focuses on Biomolecules

If you were to use infrared (IR) transmission microscopy, you would appreciate its chemical quantification abilities—unless your object of study was a hydrated cell....

Shingles Vaccine May Protect Against Dementia Risk

A newly reported study by a Stanford Medicine-led team has provided what the researchers suggest is the strongest evidence yet that a vaccine can...

Why Shares of Vir Biotechnology Rose 20.4% This Week – The...

What happened Shares of Vir Biotechnology ( VIR -1.63% ) were up 20.5% so far for the week late on Friday morning, according to...

Multiple Flu Strains Neutralized by New Class of Antibodies

Researchers headed by a team at the University of Pittsburgh School of Medicine Center for Vaccine Research have identified a previously unrecognized class of...

Innovative research aims to improve wound healing and cancer therapy

Jun.-Prof. Dr. Priscilla Briquez, junior professor at the Department of General and Visceral Surgery at the Freiburg University Medical Center and member of the...

Nextgen Platform Combines VectorBuilder and Maxcyte Technologies to Boost Clinical-Grade Cell...

VectorBuilder and MaxCyte formed a strategic partnership focused on co-developing a new gene delivery solution using VectorBuilder’s MiniVec plasmid system and MaxCyte’s clinical electroporation...

Nextgen Platform Combines VectorBuilder and Maxcyte Technologies to Boost Clinical-Grade Cell...

VectorBuilder and MaxCyte formed a strategic partnership focused on co-developing a new gene delivery solution using VectorBuilder’s MiniVec plasmid system and MaxCyte’s clinical electroporation...

Nextgen Platform Combines VectorBuilder and Maxcyte Technologies to Boost Clinical-Grade Cell Engineering

VectorBuilder and MaxCyte formed a strategic partnership focused on co-developing a new gene delivery solution using VectorBuilder’s MiniVec plasmid system and MaxCyte’s clinical electroporation...

Nextgen Platform Combines VectorBuilder and Maxcyte Technologies to Boost Clinical-Grade Cell Engineering

VectorBuilder and MaxCyte formed a strategic partnership focused on co-developing a new gene delivery solution using VectorBuilder’s MiniVec plasmid system and MaxCyte’s clinical electroporation...

China Sets Framework for Advanced Therapeutic Development

China’s Order 818—Regulations on the Administration of Clinical Research and Clinical Translation and Application of Biomedical New Technologies—establishes a new commercialization pathway for cell...

more new items

Nextgen Platform Combines VectorBuilder and Maxcyte Technologies to Boost Clinical-Grade Cell...

VectorBuilder and MaxCyte formed a strategic partnership focused on co-developing a new gene delivery solution using VectorBuilder’s MiniVec plasmid system and MaxCyte’s clinical electroporation...

Nextgen Platform Combines VectorBuilder and Maxcyte Technologies to Boost Clinical-Grade Cell...

VectorBuilder and MaxCyte formed a strategic partnership focused on co-developing a new gene delivery solution using VectorBuilder’s MiniVec plasmid system and MaxCyte’s clinical electroporation...

China Sets Framework for Advanced Therapeutic Development

China’s Order 818—Regulations on the Administration of Clinical Research and Clinical Translation and Application of Biomedical New Technologies—establishes a new commercialization pathway for cell...